Literature DB >> 8612477

Guidelines for the drug treatment of hypertensive crises.

M M Hirschl1.   

Abstract

Hypertensive crises are a group of clinicopathological entities in which rapid reduction of hypertension is necessary to prevent serious end-organ damage. The diagnosis and treatment plan depends on the identification of specific end-organ dysfunction. The goal of treatment is to limit the progression of end-organ damage in patients with hypertensive crises. Several potent antihypertensive drugs, such as sodium nitroprusside, labetalol and urapidil, are available to produce an immediate fall in blood pressure. The choice of the drug should be made on the basis of its pharmacodynamic properties, clinical effects, advantages and contraindications. Additionally, rapid reduction of blood pressure carries a considerable risk, if it is performed in an uncontrolled manner, leading to further end-organ damage. The aim of the treatment is not just to reduce blood pressure, but to do so with minimal adverse effects while preserving organ function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8612477     DOI: 10.2165/00003495-199550060-00007

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  48 in total

1.  Oral nifedipine vs oral clonidine in the treatment of urgent hypertension.

Authors:  M Jaker; S Atkin; M Soto; G Schmid; F Brosch
Journal:  Arch Intern Med       Date:  1989-02

2.  Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies.

Authors:  J J O'Mailia; G E Sander; T D Giles
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

3.  Hypertensive encephalopathy.

Authors:  H B Dinsdale
Journal:  Stroke       Date:  1982 Sep-Oct       Impact factor: 7.914

4.  Hemodynamic effects of intravenous hydralazine in pregnant women with severe hypertension.

Authors:  J Kuzniar; A Skret; A Piela; Z Szmigiel; T Zaczek
Journal:  Obstet Gynecol       Date:  1985-10       Impact factor: 7.661

5.  Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis.

Authors:  F T Huysmans; T A Thien; R A Koene
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

6.  Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.

Authors:  M Renard; A Rivière; P Jacobs; R Bernard
Journal:  Br Heart J       Date:  1983-06

7.  Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension.

Authors:  W D Bussmann; P Kenedi; H J von Mengden; H P Nast; N Rachor
Journal:  Clin Investig       Date:  1992-12

8.  Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.

Authors:  G Gross; G Hanft; N Kolassa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.

Authors:  M M Hirschl; D Seidler; A Zeiner; A Wagner; G Heinz; F Sterz; A N Laggner
Journal:  Am J Emerg Med       Date:  1993-11       Impact factor: 2.469

10.  Clinical evaluation of different doses of intravenous enalaprilat in patients with hypertensive crises.

Authors:  M M Hirschl; M Binder; A Bur; H Herkner; M Brunner; M Müllner; F Sterz; A N Laggner
Journal:  Arch Intern Med       Date:  1995-11-13
View more
  7 in total

Review 1.  Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.

Authors:  R N Brogden; A Markham
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

Review 2.  Urapidil. A reappraisal of its use in the management of hypertension.

Authors:  M Dooley; K L Goa
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

Review 3.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

4.  The nitura study--effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema.

Authors:  W Schreiber; C Woisetschläger; M Binder; A Kaff; H Raab; M M Hirschl
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 5.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

6.  Efficacy of intravenous sedation and oral nifedipine in dental implant patients with preoperative hypertension - a retrospective study of 516 cases.

Authors:  Motoshi Kimura; Yoshihiro Takasugi; Shigeyoshi Hanano; Katsuyuki Terabe; Yuko Kimura
Journal:  Int J Implant Dent       Date:  2015-03-18

Review 7.  Clinical review: the management of hypertensive crises.

Authors:  Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2003-07-16       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.